Literature DB >> 28757815

Insulin induces a shift in lipid and primary carbon metabolites in a model of fasting-induced insulin resistance.

Keedrian I Olmstead1,2, Michael R La Frano3,4,5, Johannes Fahrmann3,6, Dmitry Grapov3, Jose A Viscarra2, John W Newman3,4, Oliver Fiehn3,7, Daniel E Crocker8, Fabian V Filipp1,2,3, Rudy M Ortiz2.   

Abstract

INTRODUCTION: Prolonged fasting in northern elephant seals (NES) is characterized by a reliance on lipid metabolism, conservation of protein, and reduced plasma insulin. During early fasting, glucose infusion previously reduced plasma free fatty acids (FFA); however, during late-fasting, it induced an atypical elevation in FFA despite comparable increases in insulin during both periods suggestive of a dynamic shift in tissue responsiveness to glucose-stimulated insulin secretion.
OBJECTIVE: To better assess the contribution of insulin to this fasting-associated shift in substrate metabolism.
METHODS: We compared the responses of plasma metabolites (amino acids (AA), FFA, endocannabinoids (EC), and primary carbon metabolites (PCM)) to an insulin infusion (65 mU/kg) in early- and late-fasted NES pups (n = 5/group). Plasma samples were collected prior to infusion (T0) and at 10, 30, 60, and 120 min post-infusion, and underwent untargeted and targeted metabolomics analyses utilizing a variety of GC-MS and LC-MS technologies.
RESULTS: In early fasting, the majority (72%) of metabolite trajectories return to baseline levels within 2 h, but not in late fasting indicative of an increase in tissue sensitivity to insulin. In late-fasting, increases in FFA and ketone pools, coupled with decreases in AA and PCM, indicate a shift toward lipolysis, beta-oxidation, ketone metabolism, and decreased protein catabolism. Conversely, insulin increased PCM AUC in late fasting suggesting that gluconeogenic pathways are activated. Insulin also decreased FFA AUC between early and late fasting suggesting that insulin suppresses triglyceride hydrolysis.
CONCLUSION: Naturally adapted tolerance to prolonged fasting in these mammals is likely accomplished by suppressing insulin levels and activity, providing novel insight on the evolution of insulin during a condition of temporary, reversible insulin resistance.

Entities:  

Keywords:  Endocannabinoids; Fatty acids; Lipidomics; Metabolomics; Substrate metabolism

Year:  2017        PMID: 28757815      PMCID: PMC5526460          DOI: 10.1007/s11306-017-1186-y

Source DB:  PubMed          Journal:  Metabolomics        ISSN: 1573-3882            Impact factor:   4.290


  68 in total

Review 1.  Insulin: understanding its action in health and disease.

Authors:  P Sonksen; J Sonksen
Journal:  Br J Anaesth       Date:  2000-07       Impact factor: 9.166

2.  Extending the breadth of metabolite profiling by gas chromatography coupled to mass spectrometry.

Authors:  Oliver Fiehn
Journal:  Trends Analyt Chem       Date:  2008-03       Impact factor: 12.296

3.  Compensatory mechanism for homeostatic blood pressure regulation in Ephx2 gene-disrupted mice.

Authors:  Ayala Luria; Steven M Weldon; Alisa K Kabcenell; Richard H Ingraham; Damian Matera; Huiping Jiang; Rajan Gill; Christophe Morisseau; John W Newman; Bruce D Hammock
Journal:  J Biol Chem       Date:  2006-11-29       Impact factor: 5.157

4.  Quantitative metabolomics by H-NMR and LC-MS/MS confirms altered metabolic pathways in diabetes.

Authors:  Ian R Lanza; Shucha Zhang; Lawrence E Ward; Helen Karakelides; Daniel Raftery; K Sreekumaran Nair
Journal:  PLoS One       Date:  2010-05-10       Impact factor: 3.240

5.  Clinical usefulness of serum 1,5-anhydroglucitol in monitoring glycaemic control.

Authors:  T Yamanouchi; N Ogata; T Tagaya; T Kawasaki; N Sekino; H Funato; L Akaoka; H Miyashita
Journal:  Lancet       Date:  1996-06-01       Impact factor: 79.321

6.  Plasma acylcarnitine profiles suggest incomplete long-chain fatty acid beta-oxidation and altered tricarboxylic acid cycle activity in type 2 diabetic African-American women.

Authors:  Sean H Adams; Charles L Hoppel; Kerry H Lok; Ling Zhao; Scott W Wong; Paul E Minkler; Daniel H Hwang; John W Newman; W Timothy Garvey
Journal:  J Nutr       Date:  2009-04-15       Impact factor: 4.798

7.  Plasma carnitine in fasting neonatal and adult northern elephant seals.

Authors:  S H Adams; D P Costa; S C Winter
Journal:  Am J Physiol       Date:  1992-09

8.  Insulin and GLP-1 infusions demonstrate the onset of adipose-specific insulin resistance in a large fasting mammal: potential glucogenic role for GLP-1.

Authors:  Jose A Viscarra; Ruben Rodriguez; Jose Pablo Vazquez-Medina; Andrew Lee; Michael S Tift; Stephen K Tavoni; Daniel E Crocker; Rudy M Ortiz
Journal:  Physiol Rep       Date:  2013-08

9.  Metabolic profiling of the response to an oral glucose tolerance test detects subtle metabolic changes.

Authors:  Suzan Wopereis; Carina M Rubingh; Marjan J van Erk; Elwin R Verheij; Trinette van Vliet; Nicole H P Cnubben; Age K Smilde; Jan van der Greef; Ben van Ommen; Henk F J Hendriks
Journal:  PLoS One       Date:  2009-02-26       Impact factor: 3.240

Review 10.  A non-traditional model of the metabolic syndrome: the adaptive significance of insulin resistance in fasting-adapted seals.

Authors:  Dorian S Houser; Cory D Champagne; Daniel E Crocker
Journal:  Front Endocrinol (Lausanne)       Date:  2013-11-01       Impact factor: 5.555

View more
  1 in total

1.  Oxylipin responses to fasting and insulin infusion in a large mammalian model of fasting-induced insulin resistance, the northern elephant seal.

Authors:  Dana N Wright; Kondwani G H Katundu; Jose A Viscarra; Daniel E Crocker; John W Newman; Michael R La Frano; Rudy M Ortiz
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2021-08-04       Impact factor: 3.210

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.